Martinex R&D, Inc.
Records under this name other than patents Martinex R&D, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,288,034 | Recombinant human alpha-fetoprotein as an immunosuppressive agent Formerly held Term ended Term ended Nov 5, 2018 · USPTO record | Term ended | Term ended Nov 5, 2018 | USPTO record |
| US 6,107,612 | Heating device and method Formerly held Term ended Term ended Jan 26, 2018 · USPTO record | Term ended | Term ended Jan 26, 2018 | USPTO record |
| US 6,416,734 | Recombinant alpha-fetoprotein for treating and diagnosing cancers Formerly held Term ended Term ended Jan 24, 2015 · USPTO record | Term ended | Term ended Jan 24, 2015 | USPTO record |
| US 6,534,479 | Recombinant alpha-fetoprotein hybrid cytotoxins for treating and diagnosing cancers Formerly held Term ended Term ended Jan 24, 2015 · USPTO record | Term ended | Term ended Jan 24, 2015 | USPTO record |
| US 6,630,445 | Recombinant Alpha-Fetoprotein for Treating Cancers Formerly held Term ended Ended no later than Jan 24, 2015 · Low confidence | Term ended | Ended no later than Jan 24, 2015 | Low confidence |
| US 6,774,108 | Recombinant Human Alpha-Fetoprotein as an Immunosuppressive Agent Formerly held Term ended Ended no later than Jan 24, 2015 · Low confidence | Term ended | Ended no later than Jan 24, 2015 | Low confidence |
| US 7,101,837 | Recombinant human alpha-fetoprotein as a cell proliferative agent Formerly held Lapsed on the fee record Ended Sep 5, 2014 · USPTO record | Lapsed on the fee record | Ended Sep 5, 2014 | USPTO record |
| US 6,331,611 | Expression and purification of cloned human alpha-fetoprotein Formerly held Lapsed on the fee record Ended Dec 18, 2013 · USPTO record | Lapsed on the fee record | Ended Dec 18, 2013 | USPTO record |
| US 7,423,024 | Recombinant Human Alpha-Fetoprotein as an Immunosuppressive Agent Formerly held Lapsed on the fee record Ended Sep 9, 2012 · Medium confidence | Lapsed on the fee record | Ended Sep 9, 2012 | Medium confidence |
| US 6,627,440 | Recombinant human alpha-fetoprotein as a cell proliferative agent Formerly held Lapsed on the fee record Ended Sep 30, 2011 · USPTO record | Lapsed on the fee record | Ended Sep 30, 2011 | USPTO record |